AlphAIAlphAI — Financial news for AI agents
beinsure.com$RKLB

Rocket Lab (RKLB) stock price forecast: Record $3.6 bn backlog and Q3 earnings reshape 2027 outlook

Rocket Lab (RKLB) reported Q3 2026 revenue of $267.8 mn, up 73% YoY, with a $3.57 bn backlog. The company generated $7.2 mn in positive operating cash flow but posted a $79.7 mn net loss. RKLB shares closed at $58.86, with a 12-month average price target of $102.15. Neutron's delayed launch and Iridium acquisition pose risks.

Original reporting
beinsure.com
Published Nov 9, 2026, 10:11 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 9, 2026, 11:28 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
Rocket Lab (RKLB) stock price forecast: Record $3.6 bn backlog and Q3 earnings reshape 2027 outlook — source image
Source · beinsure.com
Decision brief

The 30-second read

$RKLBBearishHigh
01

Why it matters

Earnings beat revenue guidance but profitability concerns dominate, likely pressuring the stock in after‑hours trading.

02

Market read

Earnings release provides fresh material for traders; stock moved 10.9% up intraday then fell 4.5% after‑hours.

03

What to watch

Iridium acquisition may provide recurring revenue that offsets dilution concerns.

Relevance 9/10Novelty 9/10Timing: after‑hours today

Background

Rocket Lab posted Q3 2026 results with record revenue and backlog, but a widened loss and delayed Neutron launch.

Company-level read

Ticker impact

$RKLBBearishHigh confidence
Context

Q3 2026 earnings report showing record revenue, a $79.7M net loss and a 4.5% after‑hours price drop.

Expected impact

likely pressure as market prices in the widened loss and launch schedule risk

Evidence & confidence

Investors focus on profitability and execution risk despite strong backlog; similar patterns have driven short‑term sell‑offs.

Market effects

Sector

Highlights growth in small‑sat launch market but underscores execution risk for medium‑lift rockets.

Regional

U.S. space‑services sector may see modest pullback pending Neutron progress.

Global

Limited to aerospace investors; broader market unlikely to be affected.

Counterpoint

What could challenge this read

Backlog strength could eventually translate to outsized upside if Neutron launches on schedule.

Key entities

  • company
    Rocket Lab

    U.S.-listed space launch provider (NASDAQ: RKLB).

Read at source← All news

StoryRocket Lab posts record Q3 2026 revenue and backlog amid Neutron delay and Iridium acquisition

Also covered by

6 outlets

Related articles

$RKLBHighAI 8/10

Why Rocket Lab Stock Is Falling After Hours as Take-Two Surges — and What Wall Street Sees Next

Rocket Lab (RKLB) fell 4% after reporting a larger-than-expected loss despite revenue growth, while Take-Two (TTWO) rose 4% on strong preorders for Grand Theft Auto VI and reaffirmed annual outlook. RKLB's Q3 revenue grew 72.7% to $267.8M, but its loss of $0.12 per share missed estimates. TTWO's Q2 bookings missed forecasts but its updated fiscal 2027 outlook was raised. Both stocks have Strong Buy ratings from analysts.

tipranks.com
$RKLBHigh

Rocket Lab Q4 Guidance: Sales $270M-$290M vs $265.4M Est

Rocket Lab reported Q3 revenue of $267.83M, beating estimates, but posted a loss of $0.12 per share. The company guided Q4 revenue to $270M-$290M. Shares fell 6.61% in after-hours trading. Rocket Lab's backlog grew to $3.57B, with $1B in new launch contracts. The Neutron rocket's first launch is delayed to 2027. The company plans to acquire Iridium for $8B, with closing expected by mid-2027. Analysts have a Buy rating with an average price target of $103.23.

scanx.trade